Cancer Vaccine Sustains 49 Percent Melanoma Reduction After 5 Years (opens in new tab)

The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49 percent, a new study shows. The post appeared first on <a href="